Unique Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 6.00 Cr
as on 21-06-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.26 Cr
as on 21-06-2024
- Satisfied Charges ₹ 19.12 Cr
as on 21-06-2024
- Revenue 31.64%
(FY 2023)
- Profit 26.97%
(FY 2023)
- Ebitda 22.97%
(FY 2023)
- Net Worth 23.00%
(FY 2023)
- Total Assets 23.75%
(FY 2023)
About Unique Biotech
The Corporate was formerly known as Unique Biotech Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹18.26 Cr. The company has closed loans amounting to ₹19.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Unique Biotech Limited India is Manish Shukla as COMPANY SECRETARY. Ratna Madempudi, Jawahar Medempudi, Venkata Ravella, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG1999PLC031113
- Company No.
031113
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Feb 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Unique Biotech Limited offer?
Unique Biotech Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Health Care Equipment, Nutraceuticals, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Saccharomyces Boulardii, Animal Medicines & Health Care.
Who are the key members and board of directors at Unique Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratna Madempudi  | Managing Director | 15-Feb-1999 | Current |
| Manish Shukla | Company Secretary | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Madempudi | Director | Current | |
| Jawahar Medempudi | Whole-Time Director | 01-Jan-2009 | Current |
| Venkata Ravella | Director | 15-Feb-1999 | Current |
| Durga Vajjha | Director | Current |
Financial Performance of Unique Biotech.
Unique Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.64% increase. The company also saw a substantial improvement in profitability, with a 26.97% increase in profit. The company's net worth Soared by an impressive increase of 23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unique Biotech?
In 2023, Unique Biotech had a promoter holding of 89.49% and a public holding of 10.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jun 2015 | ₹18.26 Cr | Open |
Canara Bank Creation Date: 15 Nov 2010 | ₹2.00 Cr | Satisfied |
Kotak Mahindra Bank Limited Creation Date: 12 May 2009 | ₹3.06 M | Satisfied |
How Many Employees Work at Unique Biotech?
Unique Biotech has a workforce of 346 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unique Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unique Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
